Seguir
Marco Davila
Marco Davila
Transplantation and Cellular Therapy, Roswell Park Comprehensive Cancer Center
Dirección de correo verificada de roswellpark.org
Título
Citado por
Citado por
Año
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
ML Davila, I Riviere, X Wang, S Bartido, J Park, K Curran, SS Chung, ...
Science translational medicine 6 (224), 224ra25-224ra25, 2014
28032014
CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia
RJ Brentjens, ML Davila, I Riviere, J Park, X Wang, LG Cowell, S Bartido, ...
Science translational medicine 5 (177), 177ra38-177ra38, 2013
23972013
CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia
RJ Brentjens, ML Davila, I Riviere, J Park, X Wang, LG Cowell, S Bartido, ...
Science translational medicine 5 (177), 177ra38-177ra38, 2013
23972013
Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia
JH Park, I Rivière, M Gonen, X Wang, B Sénéchal, KJ Curran, C Sauter, ...
New England Journal of Medicine 378 (5), 449-459, 2018
23382018
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
RJ Brentjens, I Rivière, JH Park, ML Davila, X Wang, J Stefanski, C Taylor, ...
Blood, The Journal of the American Society of Hematology 118 (18), 4817-4828, 2011
15402011
Distinct regulation of Th17 and Th1 cell differentiation by glutaminase-dependent metabolism
MO Johnson, MM Wolf, MZ Madden, G Andrejeva, A Sugiura, ...
Cell 175 (7), 1780-1795. e19, 2018
4912018
Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome
V Staedtke, RY Bai, K Kim, M Darvas, ML Davila, GJ Riggins, ...
Nature 564 (7735), 273-277, 2018
2512018
CD19 CAR-targeted T cells induce long-term remission and B Cell Aplasia in an immunocompetent mouse model of B cell acute lymphoblastic leukemia
ML Davila, CC Kloss, G Gunset, M Sadelain
PloS one 8 (4), e61338, 2013
2322013
Donor CD19 CAR T cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity
A Ghosh, M Smith, SE James, ML Davila, E Velardi, KV Argyropoulos, ...
Nature medicine 23 (2), 242-249, 2017
2182017
CAR models: next-generation CAR modifications for enhanced T-cell function
D Abate-Daga, ML Davila
Molecular Therapy-Oncolytics 3, 2016
2052016
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events
MV Maus, S Alexander, MR Bishop, JN Brudno, C Callahan, ML Davila, ...
Journal for immunotherapy of cancer 8 (2), 2020
1762020
Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma
JM Logue, E Zucchetti, CA Bachmeier, GS Krivenko, V Larson, D Ninh, ...
Haematologica 106 (4), 978, 2021
1712021
Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma
MD Jain, H Zhao, X Wang, R Atkins, M Menges, K Reid, K Spitler, ...
Blood, The Journal of the American Society of Hematology 137 (19), 2621-2633, 2021
1622021
High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma
EA Dean, RS Mhaskar, H Lu, MS Mousa, GS Krivenko, A Lazaryan, ...
Blood Advances 4 (14), 3268-3276, 2020
1552020
How do CARs work? Early insights from recent clinical studies targeting CD19
ML Davila, R Brentjens, X Wang, I Rivière, M Sadelain
Oncoimmunology 1 (9), 1577-1583, 2012
1542012
CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas
M Gang, ND Marin, P Wong, CC Neal, L Marsala, M Foster, T Schappe, ...
Blood, The Journal of the American Society of Hematology 136 (20), 2308-2318, 2020
1492020
CD19-Targeted CAR T cells as novel cancer immunotherapy for relapsed or refractory B-cell acute lymphoblastic leukemia
ML Davila, RJ Brentjens
Clinical advances in hematology & oncology: H&O 14 (10), 802, 2016
1382016
Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies
ML Davila, DCG Bouhassira, JH Park, KJ Curran, EL Smith, HJ Pegram, ...
International journal of hematology 99, 361-371, 2014
1322014
Radiation therapy as a bridging strategy for CAR T cell therapy with axicabtagene ciloleucel in diffuse large B-cell lymphoma
AJ Sim, MD Jain, NB Figura, JC Chavez, BD Shah, F Khimani, A Lazaryan, ...
International Journal of Radiation Oncology* Biology* Physics 105 (5), 1012-1021, 2019
1242019
4-1BB enhancement of CAR T function requires NF-κB and TRAFs
G Li, JC Boucher, H Kotani, K Park, Y Zhang, B Shrestha, X Wang, L Guan, ...
JCI insight 3 (18), 2018
1212018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20